Here's What's Behind Nektar Therapeutics' 20% Move Higher

What happened Shares of Nektar Therapeutics NASDAQ NKTR a biopharmaceutical company that utilizes its proprietary intellectual property via licensing deals and through collaborations in the clinical development process to help fight cancer autoimmune diseases and